Michaël Maes

82.9k total citations · 16 hit papers
1.0k papers, 62.7k citations indexed

About

Michaël Maes is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Michaël Maes has authored 1.0k papers receiving a total of 62.7k indexed citations (citations by other indexed papers that have themselves been cited), including 483 papers in Biological Psychiatry, 329 papers in Behavioral Neuroscience and 295 papers in Psychiatry and Mental health. Recurrent topics in Michaël Maes's work include Tryptophan and brain disorders (483 papers), Stress Responses and Cortisol (329 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (115 papers). Michaël Maes is often cited by papers focused on Tryptophan and brain disorders (483 papers), Stress Responses and Cortisol (329 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (115 papers). Michaël Maes collaborates with scholars based in Thailand, Australia and Belgium. Michaël Maes's co-authors include Michael Berk, Marta Kubera, Eugène Bosmans, George Anderson, Herbert Y. Meltzer, Gerwyn Morris, Simon Scharpé, Günter Kenis, Marieke Wichers and André F. Carvalho and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and PLoS ONE.

In The Last Decade

Michaël Maes

1.0k papers receiving 60.7k citations

Hit Papers

Peripheral cytokine and... 1995 2026 2005 2015 2017 2013 2005 2010 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
    2017 1.1k citations Michaël Maes, Marco Solmi et al. profile →
  2. So depression is an inflammatory disease, but where does the inflammation come from?
    2013 1.0k citations Michaël Maes et al. profile →
  3. Cytokines and major depression
    2005 952 citations Michaël Maes et al. profile →
  4. Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
    2010 932 citations Michaël Maes, Clarissa Severino Gama et al. profile →
  5. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
    2010 927 citations Michaël Maes et al. profile →
  6. Evidence for an immune response in major depression: A review and hypothesis
    1995 800 citations Michaël Maes profile →
  7. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
    2008 720 citations Michaël Maes, Marta Kubera et al. profile →
  8. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
    2011 674 citations Michaël Maes et al. profile →
  9. THE EFFECTS OF PSYCHOLOGICAL STRESS ON HUMANS: INCREASED PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND Th1-LIKE RESPONSE IN STRESS-INDUCED ANXIETY
    1998 632 citations Michaël Maes, Eugène Bosmans et al. Cytokine profile →
  10. INCREASED SERUM IL-6 AND IL-1 RECEPTOR ANTAGONIST CONCENTRATIONS IN MAJOR DEPRESSION AND TREATMENT RESISTANT DEPRESSION
    1997 571 citations Michaël Maes, Eugène Bosmans et al. Cytokine profile →
  11. The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
    2010 553 citations Michaël Maes, Marta Kubera et al. profile →
  12. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
    1995 514 citations Michaël Maes, Eugène Bosmans et al. Journal of Affective Disorders profile →
  13. Major Depression and Activation of The Inflammatory Response System
    1999 507 citations Michaël Maes profile →
  14. Redox regulation of the immune response
    2022 322 citations Michaël Maes et al. profile →
  15. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019
    2023 185 citations Marco Solmi, Michaël Maes et al. profile →
  16. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
    2023 76 citations Aristo Vojdani, Michaël Maes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Maes Thailand 123 28.4k 19.2k 14.2k 9.8k 7.3k 1.0k 62.7k
Andrew H. Miller United States 94 19.7k 0.7× 18.4k 1.0× 5.6k 0.4× 4.2k 0.4× 3.9k 0.5× 345 43.6k
Michael Berk Australia 125 15.9k 0.6× 6.5k 0.3× 22.7k 1.6× 9.4k 1.0× 8.4k 1.1× 1.4k 68.2k
Charles B. Nemeroff United States 137 14.7k 0.5× 24.5k 1.3× 10.3k 0.7× 11.1k 1.1× 5.6k 0.8× 974 77.0k
Timothy G. Dinan Ireland 127 19.1k 0.7× 9.6k 0.5× 6.2k 0.4× 34.6k 3.5× 17.8k 2.4× 639 64.6k
Carmine M. Pariante United Kingdom 100 12.7k 0.4× 13.1k 0.7× 6.5k 0.5× 3.8k 0.4× 2.7k 0.4× 495 38.0k
John F. Cryan Ireland 138 22.1k 0.8× 11.3k 0.6× 4.9k 0.3× 42.7k 4.3× 21.6k 3.0× 744 79.8k
Brenda W.J.H. Penninx Netherlands 138 10.2k 0.4× 9.5k 0.5× 10.5k 0.7× 4.0k 0.4× 11.7k 1.6× 989 74.1k
George P. Chrousos Greece 147 6.7k 0.2× 25.4k 1.3× 6.2k 0.4× 11.4k 1.2× 15.4k 2.1× 1.4k 96.8k
Dennis S. Charney United States 151 15.7k 0.6× 15.8k 0.8× 16.0k 1.1× 6.8k 0.7× 3.5k 0.5× 582 84.3k
John H. Krystal United States 133 11.8k 0.4× 6.5k 0.3× 11.3k 0.8× 7.8k 0.8× 3.4k 0.5× 651 60.2k

Countries citing papers authored by Michaël Maes

Since Specialization
Citations

This map shows the geographic impact of Michaël Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Maes more than expected).

Fields of papers citing papers by Michaël Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Maes. The network helps show where Michaël Maes may publish in the future.

Co-authorship network of co-authors of Michaël Maes

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Maes. A scholar is included among the top collaborators of Michaël Maes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Maes. Michaël Maes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sisler, Jennifer D., Patrik Andersson, Carole E. Harbison, et al.. (2026). An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics. International Journal of Toxicology. 45(2). 127–135.
2.
3.
4.
5.
6.
Vasupanrajit, Asara, Michaël Maes, Ketsupar Jirakran, & Chavit Tunvirachaisakul. (2023). Brooding and neuroticism are strongly interrelated manifestations of the phenome of depression. Frontiers in Psychiatry. 14. 1249839–1249839. 6 indexed citations
7.
Almulla, Abbas F., et al.. (2023). Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis. Brain Behavior and Immunity. 113. 374–388. 44 indexed citations
8.
Al‐Hakeim, Hussein Kadhem, et al.. (2023). Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease. Journal of Affective Disorders. 347. 220–229. 6 indexed citations
9.
Gama, Clarissa Severino, et al.. (2023). Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis. European Neuropsychopharmacology. 73. 82–95. 13 indexed citations
10.
Al‐Hakeim, Hussein Kadhem, et al.. (2023). Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID. Frontiers in Molecular Neuroscience. 16. 1194769–1194769. 24 indexed citations
11.
Simão, Andréa Name Colado, Sayonara Rangel Oliveira, Elaine Regina Delicato de Almeida, et al.. (2023). Protective effects of IL18-105G > A and IL18-137C > G genetic variants on severity of COVID-19. Cytokine. 174. 156476–156476.
12.
Vasupanrajit, Asara, Ketsupar Jirakran, Chavit Tunvirachaisakul, Marco Solmi, & Michaël Maes. (2021). Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis. medRxiv. 5 indexed citations
13.
Curzytek, Katarzyna, Michaël Maes, & Marta Kubera. (2021). Immune-Regulatory and Molecular Effects of Antidepressants on the Inflamed Human Keratinocyte HaCaT Cell Line. Neurotoxicity Research. 39(4). 1211–1226. 8 indexed citations
14.
Matsumoto, Andressa Keiko, Michaël Maes, Ana Paula Michelin, et al.. (2020). Vitamin D deficiency is not associated with increased oxidative stress in chronic kidney disease pre-dialysis patients. Brazilian Journal of Nephrology. 42(4). 420–428. 2 indexed citations
15.
16.
17.
Anderson, George, Michaël Maes, Regina P. Markus, & Moses Rodriguez. (2015). Ebola virus: Melatonin as a readily available treatment option. Journal of Medical Virology. 87(4). 537–543. 42 indexed citations
18.
Maes, Michaël, Ivanka Mihaylova, Marta Kubera, et al.. (2009). Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.. PubMed. 30(4). 462–9. 134 indexed citations
19.
Maes, Michaël, et al.. (1997). NEU volume 9 issue 4 Cover and Front matter. Acta Neuropsychiatrica. 9(4). f1–f5. 1 indexed citations
20.
Maes, Michaël, et al.. (1988). EPP volume 3 issue 6 Cover and Front matter. 3(6). f1–f6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew H. Miller Breakdown of academic impact, for papers by Michael Berk Breakdown of academic impact, for papers by Charles B. Nemeroff Breakdown of academic impact, for papers by Timothy G. Dinan Breakdown of academic impact, for papers by Carmine M. Pariante Breakdown of academic impact, for papers by John F. Cryan Breakdown of academic impact, for papers by Brenda W.J.H. Penninx Breakdown of academic impact, for papers by George P. Chrousos Breakdown of academic impact, for papers by Dennis S. Charney Breakdown of academic impact, for papers by John H. Krystal
Rankless by CCL
2026